Your SlideShare is downloading. ×
0
MeTA in Peru DR. MELITON ARCE RODRIGUEZ VICE MINISTRO DE SALUD (on behalf of the Peruvian Delegation) 16/05/2008
Basic info about MeTA in Peru <ul><li>Just beginning the process!  </li></ul><ul><ul><li>First visit from a MeTA represent...
Key Issues <ul><li>Universal access independently of economy, social class, geography, race or ethnicity  </li></ul><ul><l...
Machu Picchu:  One of the Seven Wonders of the World! 06/04/09
Transparency & Accountability <ul><li>Some Current Areas of Work  </li></ul><ul><ul><li>Observatory in Medicines </li></ul...
Transparency and Accountability <ul><ul><li>Consejo Nacional de Salud </li></ul></ul><ul><ul><ul><li>A body which drives t...
MeTA structures in Peru <ul><li>Early stages of the process </li></ul><ul><ul><li>Our task force (delegation) is discussin...
Main areas of work for MeTA <ul><li>Issues of supply – overstock and understock </li></ul><ul><li>Issue of quality of medi...
Main areas of work for MeTA <ul><li>Need to unify national essential essential medicines list (each sector has its own…pol...
National research needs <ul><li>Price differentials for consumers in different parts of the country </li></ul><ul><li>Eval...
Lessons learned so far… <ul><li>Importance of a multistakeholder approach </li></ul><ul><li>Necessary to create alliances ...
Challenges, risks <ul><li>The need for public policies to be sustainable  </li></ul><ul><li>Preserve the global accords WH...
Support needs? <ul><li>Support for a local technical secretariat to organize a national forum </li></ul><ul><li>Financial ...
Thank you! <ul><li>Vice Minister of Health  </li></ul><ul><li>Dr.Elias Meliton Arce Rodriguez </li></ul><ul><li>[email_add...
Upcoming SlideShare
Loading in...5
×

Medicines Transparency In Peru

1,528

Published on

Presentation on medicines transparency in Peru at the launch of the Medicines Transparency Alliance in London, May 2008

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,528
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
14
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Title of presentation 04/06/09 MeTA
  • Transcript of "Medicines Transparency In Peru"

    1. 1. MeTA in Peru DR. MELITON ARCE RODRIGUEZ VICE MINISTRO DE SALUD (on behalf of the Peruvian Delegation) 16/05/2008
    2. 2. Basic info about MeTA in Peru <ul><li>Just beginning the process! </li></ul><ul><ul><li>First visit from a MeTA representative in April, 2007 </li></ul></ul><ul><ul><li>Beginning of conversations with local MeTA representative in November, 2007 </li></ul></ul><ul><ul><li>Health Minister Hernan Garrido-Lecca signed on formally to MeTA in March, 2008 </li></ul></ul>16/05/2008
    3. 3. Key Issues <ul><li>Universal access independently of economy, social class, geography, race or ethnicity </li></ul><ul><li>Provision of safe and efficient medicines, including quality control </li></ul><ul><li>National essential medicines list which is unified and current </li></ul><ul><li>Permanent updating of technology for medicines </li></ul><ul><li>Promote the use of generic drugs </li></ul>16/05/2008
    4. 4. Machu Picchu: One of the Seven Wonders of the World! 06/04/09
    5. 5. Transparency & Accountability <ul><li>Some Current Areas of Work </li></ul><ul><ul><li>Observatory in Medicines </li></ul></ul><ul><ul><ul><li>DIGEMID y AIS (HAI) </li></ul></ul></ul><ul><ul><li>Defensoria del Pueblo </li></ul></ul><ul><ul><ul><li>A report regarding the system for supply of medicines in public sector </li></ul></ul></ul><ul><ul><ul><li>Responding to demands regarding public services </li></ul></ul></ul>16/05/2008
    6. 6. Transparency and Accountability <ul><ul><li>Consejo Nacional de Salud </li></ul></ul><ul><ul><ul><li>A body which drives the national health system </li></ul></ul></ul><ul><ul><ul><li>Minister of Health presides </li></ul></ul></ul><ul><ul><ul><li>Multisectoral in 19 different topics, including medicines: public, private health providers as well as civil society (11 institutions participate) </li></ul></ul></ul><ul><ul><ul><li>Consultation and consensus-building body on public policies in health </li></ul></ul></ul><ul><ul><li>ForoSalud </li></ul></ul><ul><ul><ul><li>Participation of civil society in vigilence of medicines access and quality </li></ul></ul></ul><ul><ul><ul><li>Regional tables working specifically on medicines access in a number of regions of the country </li></ul></ul></ul><ul><ul><ul><li>Has a seat on the Consejo Nacional de Salud and brings to Table issues raised regionally </li></ul></ul></ul>16/05/2008
    7. 7. MeTA structures in Peru <ul><li>Early stages of the process </li></ul><ul><ul><li>Our task force (delegation) is discussing how best to structure </li></ul></ul><ul><li>Interest in the some possible structures </li></ul><ul><ul><li>Secretaria Ejecutiva </li></ul></ul><ul><ul><li>Multistakeholder approach </li></ul></ul><ul><ul><li>Development of a national workplan </li></ul></ul><ul><ul><li>Ministry of Health as champion and chair of the process </li></ul></ul>16/05/2008
    8. 8. Main areas of work for MeTA <ul><li>Issues of supply – overstock and understock </li></ul><ul><li>Issue of quality of medicines: </li></ul><ul><ul><li>Lax medicines registration </li></ul></ul><ul><ul><li>Quality control </li></ul></ul><ul><ul><li>Create a better capacity for the state to regulate medicines </li></ul></ul><ul><ul><li>More autonomy for the drug regulatory office (DIGEMID) </li></ul></ul><ul><ul><li>Lax prescription and dispensation </li></ul></ul><ul><li>Fragmented public health system </li></ul>16/05/2008
    9. 9. Main areas of work for MeTA <ul><li>Need to unify national essential essential medicines list (each sector has its own…police, army, marines, airforce, Health Ministry, and social security ESSalud) </li></ul><ul><li>Illegal medicines (contraband, counterfeit, adulturated, expired, stolen) </li></ul><ul><li>Evaluate options regarding public private partnerships to fill the gaps of the needs of most of the population to receive their medicines </li></ul><ul><li>Need to permanently review the process for the acquisition of medicines </li></ul><ul><ul><li>Corporate purchases </li></ul></ul><ul><ul><li>Reverse auction </li></ul></ul><ul><ul><li>Quality control </li></ul></ul><ul><ul><li>Technical files </li></ul></ul>06/04/09
    10. 10. National research needs <ul><li>Price differentials for consumers in different parts of the country </li></ul><ul><li>Evaluation of work that has been done regarding improving the efficacy of the public supply chain </li></ul><ul><li>Better understanding of consumer access through public systems </li></ul><ul><li>A look at the causes of self medication </li></ul><ul><li>How to promote appropriate prescriptions </li></ul><ul><li>Factors (or not) that promote the rational use of medicines </li></ul><ul><li>A look at how pharmaceuticals influence on the prescriptors and dispensers </li></ul><ul><li>Need to unify national essential essential medicines list (each sector has its own…police, army, marines, airforce, Health Ministry, and social security ESSalud) </li></ul><ul><li>Illegal medicines (contraband, counterfeit, adulturated, expired, stolen) </li></ul><ul><li>Evaluate options regarding public private partnerships to fill the gaps of the needs of most of the population to receive their medicines </li></ul><ul><li>Understand the practice of traditional healers outside of the the formal medical establishment. </li></ul><ul><li>Harmonizing the policies among the different insititutions specifically with regard to medicines acquisition, etc. </li></ul>06/04/09
    11. 11. Lessons learned so far… <ul><li>Importance of a multistakeholder approach </li></ul><ul><li>Necessary to create alliances with other actors working in health </li></ul><ul><li>Importance of public-private partnership </li></ul><ul><li>Value of learning regarding the global experiences in the MeTA </li></ul>16/05/2008
    12. 12. Challenges, risks <ul><li>The need for public policies to be sustainable </li></ul><ul><li>Preserve the global accords WHO and Doha </li></ul><ul><li>Implementation of Free Trade Agreement (FTA) with the United States, assuring that it does not bring down standards regarding patents and second patents </li></ul><ul><li>Current debate a new medicines law in Congress which would guarantee universal access to safe, efficient and quality medicines through the strengthening of the national medicines regulator (to be approved this year). </li></ul><ul><li>Even though there are mechanisms that are being developed for transparency, these must be more efficient </li></ul>06/04/09
    13. 13. Support needs? <ul><li>Support for a local technical secretariat to organize a national forum </li></ul><ul><li>Financial support needs to implement a national workplan </li></ul><ul><li>Strengthen system of vigilence for civil society </li></ul><ul><ul><li>Help to sustain and institutionalize networks </li></ul></ul><ul><ul><li>Capacities for advocacy </li></ul></ul><ul><li>Create technical capacities </li></ul><ul><li>Networking opportunities with other MeTA pilot sites </li></ul>04/06/09
    14. 14. Thank you! <ul><li>Vice Minister of Health </li></ul><ul><li>Dr.Elias Meliton Arce Rodriguez </li></ul><ul><li>[email_address] </li></ul><ul><li>www.minsa.gob.pe </li></ul><ul><li>Members of Peru Delegation: </li></ul><ul><li>Dr. Julio Castro, Dean of the College of Physicians of Peru </li></ul><ul><li>Dr. Victor Dongo, General Director, DIGEMID </li></ul><ul><li>Mr. Edson Meza, Associate, Health Action International </li></ul><ul><li>Ing. Augusto Rey, Executive Director, ALAFARPE </li></ul><ul><li>Dra. Susana Silva, Legal Advisor, National Ombudsman’s Office </li></ul>06/04/09
    1. A particular slide catching your eye?

      Clipping is a handy way to collect important slides you want to go back to later.

    ×